BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

PURPOSE: To investigate the prognostic value of the BRAF V600E mutation and the recently identified TERT promoter mutation chr5:1,295,228C>T (C228T), individually and in their coexistence, in papillary thyroid cancer (PTC). PATIENTS AND METHODS: We performed a retrospective study of the relations...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Xing, Mingzhao, Liu, Rengyun, Liu, Xiaoli, Murugan, Avaniyapuram Kannan, Zhu, Guangwu, Zeiger, Martha A., Pai, Sara, Bishop, Justin
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145183/
https://ncbi.nlm.nih.gov/pubmed/25024077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.5094
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares